Credit Suisse Ag Forte Biosciences, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	BUY	$1.07 - $1.55 $6 - $9	6 New	6 $0
Q1 2021 May 14, 2021	SELL	$25.01 - $40.24 $2.13 Million - $3.43 Million	-85,153 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$28.66 - $46.79 $2.74 Million - $4.47 Million	-95,441 Reduced 52.85%	85,153 $3.1 Million
Q3 2020 Nov 13, 2020	BUY	$14.71 - $50.69 $2.66 Million - $9.15 Million	180,594 New	180,594 $8.76 Million

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$977,456
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $114M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.